FierceCRO Athlone

An analytical approach to biosimilar drug development

Patricia Hurley, Edward Tabler and Duu-Gong Wu talk about the impact that analytical testing on biosimilars has on their pathway to regulatory approval.

BioPharm International  (October 2018)

Ensuring Employees’ Well-Being In The Eye Of A Storm

Ron Garrow discusses how in the wake of Hurricane Florence that our employees’ well-being comes first.

Greater Wilmington Business Journal  (October 2018)

Patient centricity: Moving from a ‘nice to have’ to best practice

Rhonda Henry discusses the concept of putting the patient “front and center.”

Outsourcing-Pharma  (September 2018)

Challenging the ‘site-first’ status quo in patient enrollment

Tammy D’Lugin-Monroe and Dan Brunwasser highlight a new patient-centric enrollment model that uses a data-driven approach to identify qualified patients first.

Applied Clinical Trials  (September 2018)

An interview with PPD

Rhonda Henry discusses some of the patient recruitment issues facing the clinical trials industry.

Pharmaceutical Outsourcing  (September 2018)

PPD updates central lab tech, launches new app for investigator portal

Christopher Fikry explains how the over-arching purpose of the enhancements will improve the user experience for the company’s clients and investigative sites.

Outsourcing-Pharma  (July 2018)

Synexus debuts new patient registry in U.S. for study of longitudinal brain aging

Synexus is collaborating with the University of Exeter in the U.K. to launch a registry-based study in the U.S. to better understand how healthy brains age.

FierceBiotech  (July 2018)

Synexus launches new patient registry to support longitudinal brain aging study

Dawie Wessels explains that Synexus is looking to register 30,000 adults for the five-year study focused on identifying potential prevention methods and possible treatments for Alzheimer’s and other dementias.

Outsourcing-Pharma  (July 2018)

PPD flips the patient enrollment model and launches new site solution

Roger Smith discusses how SynexusPlus and PatientAdvantage will enhance PPD’s enrollment capabilities.

Outsourcing-Pharma   (July 2018)

PPD, NeoGenomics to integrate pathology testing for cancer trials

Collaboration will enable both companies to jointly provide a premier global oncology and specialty laboratory solution for customers.

Fierce Biotech  (June 2018)

Contact Legal Notices Modern Slavery Transparency Statement Privacy Policy

© 2018 Pharmaceutical Product Development, LLC. All rights reserved.